Syndax Pharmaceuticals SNDX Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's total operating expenses?
- Syndax Pharmaceuticals (SNDX) reported total operating expenses of $99.07M in Q1 2026.
- How has Syndax Pharmaceuticals's total operating expenses changed year-over-year?
- Syndax Pharmaceuticals's total operating expenses decreased by 4.6% year-over-year, from $103.8M to $99.07M.
- What is the long-term trend for Syndax Pharmaceuticals's total operating expenses?
- Over 4 years (2021 to 2025), Syndax Pharmaceuticals's total operating expenses has grown at a 40.8% compound annual growth rate (CAGR), from $113.49M to $445.68M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.